Skip to main content
. 2004 Feb 17;90(4):892–899. doi: 10.1038/sj.bjc.6601589

Figure 1.

Figure 1

Immunohistochemistry of β-catenin in GEJ adenocarcinomas and cell lines (β-catenin antibody, DAB and haematoxylin counterstain, magnification × 400). (A) GEJ adenocarcinoma. Strong nuclear expression of β-catenin in the tumour cells. (B) GEJ adenocarcinoma. Prominent membranous expression of β-catenin. (C) Cell line JROECL19. Strong nuclear expression of β-catenin. (D) Cell line TE-7. Membranous expression of β-catenin.